Matthew Kelly

Corporate Officer/Principal at Perspectum Group Ltd.

45 year

Consumer Services

Technology Services

Profile

Matthew Kelly is currently the Chief Innovation Officer at Perspectum Group Ltd.
He completed his undergraduate degree at The University of Manchester and his doctorate at the University of Cambridge.

Matthew Kelly active positions

Companies	Position	Start
Perspectum Group Ltd. Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom.	Corporate Officer/Principal	2015-09-30

All active positions of Matthew Kelly

Training of Matthew Kelly

The University of Manchester	Undergraduate Degree
University of Cambridge	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew Kelly's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Perspectum Group Ltd. Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom.	Technology Services